Management of Thyroid Nodules

Initial Diagnostic Evaluation

The American College of Endocrinology recommends risk stratification using serum TSH measurement and high-resolution ultrasound, followed by ultrasound-guided fine-needle aspiration (FNA) for nodules meeting specific criteria 1
The American Thyroid Association suggests that ultrasound is the only appropriate initial imaging modality for thyroid nodule characterization, providing superior visualization compared to CT or MRI 1

Microcalcifications are highly specific for papillary thyroid carcinoma, according to the National Comprehensive Cancer Network 2, 1
Marked hypoechogenicity, irregular or microlobulated margins, solid composition, absence of peripheral halo, and central hypervascularity are suspicious ultrasound features that increase the risk of malignancy 1, 2

The Bethesda System stratifies thyroid nodules into six categories with specific malignancy risks that guide management, as recommended by the American Thyroid Association 1
For Bethesda V and VI nodules, immediate referral to an endocrine surgeon for total or near-total thyroidectomy is recommended, according to the National Comprehensive Cancer Network 2, 1

Total thyroidectomy is indicated for nodules with known distant metastases, cervical lymph node metastases, extrathyroidal extension, tumor >4 cm in diameter, or poorly differentiated histology, as recommended by the National Comprehensive Cancer Network 2
Lobectomy may be considered for nodules without prior radiation exposure, distant metastases, cervical lymph node metastases, extrathyroidal extension, or tumor >4 cm in diameter, according to the American Thyroid Association 2

TSH suppression therapy with levothyroxine is recommended after surgery for malignant thyroid nodules, with target TSH levels of 0.5-2.0 mU/L for high-risk features and <0.5 mU/L for lower-risk features, as suggested by the International Journal of Surgery 4, 5
Radioactive iodine ablation is recommended after surgery to eliminate remnant thyroid tissue and potential microscopic residual tumor, according to the American Thyroid Association 1

Surveillance is the standard of care for benign nodules without compressive symptoms or cosmetic concerns, with initial ultrasound at 12-24 months and annual ultrasound surveillance if stable, as recommended by the American Thyroid Association 1
Thermal ablation may be considered for benign nodules causing compressive symptoms or cosmetic concerns when the patient has contraindications to surgery or refuses surgical intervention, according to the International Journal of Surgery 4, 5, 3